Grundler, Franziska
Ducarmon, Quinten R.
Holley, Alfred
Knufinke, Marie
Strathmeyer, Selina
Heelemann, Steffen
Geyer, Roland
Martínez-Téllez, Borja
MacArthur, Michael R
Zeller, Georg
Wilhelmi de Toledo, Françoise
Mesnage, Robin
Article History
Received: 16 June 2025
Accepted: 21 May 2026
First Online: 1 June 2026
Declarations
:
: The study protocol was approved by the Ethics Committee of the Medical Association of Baden-Württemberg, Stuttgart, Germany (approval number: F-2023-014). The study was registered at ClinicalTrials.gov (NCT05821660) prior to the start of patient recruitment. The study was conducted in accordance with the principles of the Declaration of Helsinki and the standards of Good Clinical Practice. Written informed consent was obtained from all participants.
: Not applicable.
: Authors FG, RM, AH and FWT are employees of the Buchinger Wilhelmi Development and Holding GmbH. Authors SS, SH, and RG are employees of Lifespin GmbH. The remaining authors declare no competing interests.